Ekso Bionics Holdings, Inc. Common Stock

NASDAQ:CHRN

Medical - Specialties

Healthcare
$14.38 +11.86%

+$2.44 today

Market cap
$51.24M
Beta
1.03
52W Low $2.73High $24.00

Volume 0.12M

Average 0.22M

Returns on capital

Ekso Bionics Holdings, Inc. Common Stock management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Raj Jegannathan

Chief Technology Officer————

Lawrence Lam

Chief Product Officer————

Thomas Jorgensen

Senior Vice President of Marketing————

Jerome Wong

Chief Financial Officer—52364.77K10.24%

Ying Cenly Chen

CEO & Director——2.80M78.58%

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 16, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does Ekso Bionics Holdings, Inc. Common Stock compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Management questions

Common questions about CHRN's management, answered from reported figures.

Who manages CHRN?

Ekso Bionics Holdings, Inc. Common Stock (CHRN) lists 5 active executives. The top listed executive is Raj Jegannathan, Chief Technology Officer.

Are CHRN insiders buying or selling?

Recent insider activity shows net buying of $0.00.